Concepedia

Shigeyuki Toyoizumi

ST

Statistics

Publications

9

Citations

749

H-Index

9

Active since

2011

Affiliations

Pfizer (Japan)(Current)

Pfizer (United States)

University of Occupational and Environmental Health Japan

Keio University

Tokyo Women's Medical University

Shigeyuki Toyoizumi is an author at Pfizer (Japan) specializing in pharmacology, rheumatology, and clinical pharmacology.

ORCID

Publications per year

2011–2022

9

Publications

9

Phase II study of tofacitinib (CP‐690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate

Yoshiya Tanaka, Makoto Suzuki, Hiroyuki Nakamura et al. · Arthritis Care & Research · 2011 · 299 citations

, , +14

Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

Hisashi Yamanaka, Yoshiya Tanaka, Tsutomu Takeuchi et al. · Arthritis Research & Therapy · 2016 · 154 citations · Full text

, , +13

Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study

Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka et al. · Modern Rheumatology · 2014 · 137 citations · Full text

, , +15

Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study

Akihiko Asahina, Takafumi Etoh, Atsuyuki Igarashi et al. · The Journal of Dermatology · 2016 · 84 citations · Full text

, , +12

Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data

Tsutomu Takeuchi, Hisashi Yamanaka, Kunihiro Yamaoka et al. · Modern Rheumatology · 2018 · 20 citations · Full text

, , +13

1–5 of 9